Will Clarivate achieve positive organic recurring revenue growth (>1%) for at least 2 consecutive quarters in FY2026?
Current Prediction
Why This Question Matters
Organic revenue growth is the central turnaround proof point. Gravy Gauge rates REVENUE_DURABILITY as CONDITIONAL — the 93% renewal rate and 88% recurring mix demonstrate stickiness, but organic growth has been flat. FY2026 guidance of 1-2% organic recurring growth is the first guided growth in years. If delivered, it shifts the assessment toward DURABLE. If missed, it confirms the market's structural decline thesis.
Prediction Distribution
Individual Predictions(9 runs)
ACV grew from <1% to ~2% through 2025 with guidance for 2-3% in 2026. ACV leads revenue by 1-2 quarters. If ACV guidance holds, organic recurring revenue should cross the 1% threshold by Q2-Q3 2026. Management guided 1-2% organic recurring growth for the first time — this is the first time they've guided growth in years, suggesting internal confidence. However, FY2025 organic revenue was flat, meaning the inflection must happen within the guidance year. The question requires 2 consecutive quarters above 1%, which is the base case if ACV follows through but requires consistent execution across both A&G and IP.
The 1-2% organic recurring growth guidance is the first guided growth in years. However, this management team has limited track record — the CEO acknowledged first time meeting guidance since 2019. The IP segment (~$800M, near-flat ACV) is the swing factor. Even if A&G delivers 2-3% growth, a flat or declining IP segment could keep total organic growth below 1% in some quarters. The question requires 2 consecutive quarters, which is more demanding than just a full-year average. Seasonality and lumpy renewal timing could cause one quarter to fall short.
Volume-driven ACV improvement (not just pricing) is the strongest positive signal — it suggests genuine demand growth rather than inflation pass-through. The subscription transition from transactional (A&G at 93% subscription vs. 81%) mechanically improves recurring revenue recognition. However, the transition also creates a headwind as transactional revenue declines offset subscription gains. Net organic effect is the question. Management's FY2026 guidance of 1-2% is the floor of what they believe achievable, and they've been raising guidance through 2025. Slightly below coin-flip because the IP segment must contribute.
This is a near coin-flip. The positive case: ACV at 2% growing to 2-3% leads revenue with a 1-2 quarter lag. Math says organic recurring growth should cross 1% in 2026. A&G segment is executing well (93% subscription mix, 93% renewal rate). The negative case: IP segment at flat ACV is the largest segment and could prevent company-wide growth from sustaining above 1% for two consecutive quarters. History of missed organic growth targets (first time meeting guidance since 2019) warrants caution.
The requirement for 2 consecutive quarters above 1% is the sticking point. Even with improving ACV trends, quarterly organic recurring revenue growth can fluctuate due to renewal timing, mix effects, and one-off items. FY2025 was flat — meaning Q1 2026 comparison may still be against a favorable comp. The subscription transition helps predictability but transactional runoff creates drag. Management guided 1-2% for the full year, meaning some quarters could be below 1% and others above. Getting 2 consecutive quarters above 1% is less certain than hitting 1%+ for the full year.
The ACV-to-revenue lag is the strongest bullish argument. If ACV is at 2% and accelerating to 2-3%, the mathematical base case is that recurring revenue crosses 1% growth by mid-2026. Management raised guidance throughout 2025, suggesting conservative initial guidance — the 1-2% range may be sandbaggy. Against this: the company has repeatedly disappointed on organic growth over the past 5+ years, and the IP segment is the weak link. Net assessment near coin-flip but slightly below.
ACV trends support crossing 1% organic growth, but IP segment weakness could prevent 2 consecutive quarters. Management guided 1-2% for full year but quarterly delivery is less certain. Slightly below coin-flip.
History of missed organic growth targets is the dominant signal. Even with improving ACV, IP segment at flat growth is the largest revenue contributor. Two consecutive quarters above 1% requires both A&G and IP to contribute consistently. Below coin-flip given execution history.
The ACV leading indicator at 2-3% guidance and the subscription mix improvement are genuine positives. First guided growth in years suggests management sees real momentum. But 2 consecutive quarters above 1% is a high bar for a company that just exited flat organic growth. Modestly below coin-flip.
Resolution Criteria
Resolves YES if Clarivate reports organic recurring revenue growth above 1.0% in at least two consecutive quarters during FY2026 (Q1-Q4). Resolves NO if growth remains at or below 1.0% in any two consecutive quarters.
Resolution Source
Clarivate quarterly earnings releases and 10-Q filings
Source Trigger
Organic recurring revenue growth positive for 2+ consecutive quarters (>1%)
Full multi-lens equity analysis